BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37658132)

  • 1. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
    Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
    Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
    Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
    Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells.
    Wu Y; Pi D; Zhou S; Yi Z; Dong Y; Wang W; Ye H; Chen Y; Zuo Q; Ouyang M
    Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):587-600. PubMed ID: 37092860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway.
    Liu B; Wang H
    Exp Ther Med; 2022 Jun; 23(6):394. PubMed ID: 35495610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
    Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
    Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of lncRNA NEAT1 suppresses streptococcus pneumoniae-induced ferroptosis in alveolar epithelial cells by regulating the Nrf2-GPX4 pathway.
    Xu L; Zhang L; Xiang Y; Zhang X
    Toxicon; 2024 May; 243():107705. PubMed ID: 38556062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis.
    Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
    Adv Sci (Weinh); 2023 Dec; 10(35):e2304521. PubMed ID: 37875418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer.
    Yang W; Wang Y; Huang Y; Yu J; Wang T; Li C; Yang L; Zhang P; Shi L; Yin Y; Tao K; Li R
    Biomed Pharmacother; 2023 Mar; 159():114301. PubMed ID: 36706634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
    Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
    Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
    [No Abstract]   [Full Text] [Related]  

  • 13. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.
    Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
    J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer.
    Wu W; Zhao Y; Qin B; Jiang X; Wang C; Hu R; Ma R; Lee MH; Liu H; Li K; Yuan P
    EBioMedicine; 2023 Jul; 93():104650. PubMed ID: 37343364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysionotin Induces Ferroptosis to Suppress Development of Colorectal Cancer via Promoting Nrf2 Degradation.
    Gao Z; Jiang J; Hou L; Ji F
    Oxid Med Cell Longev; 2022; 2022():1366957. PubMed ID: 35993016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
    Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
    Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
    Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
    Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis.
    Lin JF; Hu PS; Wang YY; Tan YT; Yu K; Liao K; Wu QN; Li T; Meng Q; Lin JZ; Liu ZX; Pu HY; Ju HQ; Xu RH; Qiu MZ
    Signal Transduct Target Ther; 2022 Feb; 7(1):54. PubMed ID: 35221331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.